Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02264678 |
| Title | Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | AstraZeneca |
| Indications |
triple-receptor negative breast cancer Her2-receptor negative breast cancer gastroesophageal junction adenocarcinoma |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | FRA |
CKB BOOST